Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
eli lilly
3
×
life sciences
medicxi
3
×
national blog main
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
deals
detroit blog main
detroit top stories
duchenne muscular dystrophy
fda
glaxosmithkline
incyte
indiana blog main
indiana top stories
jennifer doudna
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
a2 biotherapeutics
aduro biotech
What
bio
crispr
roundup
advance
alliance
biology
biopharma
bristol
buy
calls
changing
color
company
congress
congressional
cytokine
days
drugs
enhanced
executives
feud
files
group
growing
hours
initial
ipo
isn’t
known
kudos
later
laying
leaves
money
month
myers’s
new
notifying
ny
october
Language
unset
Current search:
medicxi
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs